These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17211914)

  • 1. Synthetic mimetics of the CD4 binding site of HIV-1 gp120 for the design of immunogens.
    Franke R; Hirsch T; Overwin H; Eichler J
    Angew Chem Int Ed Engl; 2007; 46(8):1253-5. PubMed ID: 17211914
    [No Abstract]   [Full Text] [Related]  

  • 2. A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120.
    Neffe AT; Meyer B
    Angew Chem Int Ed Engl; 2004 May; 43(22):2937-40. PubMed ID: 15170309
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional design of potential inhibitors of human immunodeficiency virus (HIV) binding to CD4+ target cells: a molecular model of gp120 predicts ligand binding.
    Gabriel JL; Mitchell WM
    Drug Des Discov; 1996 Oct; 14(2):103-14. PubMed ID: 9010617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for the interaction between focal adhesion kinase and CD4.
    Garron ML; Arthos J; Guichou JF; McNally J; Cicala C; Arold ST
    J Mol Biol; 2008 Feb; 375(5):1320-8. PubMed ID: 18078954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylation assists binding of HIV protein gp120 to human CD4 receptor.
    Wilhelm D; Behnken HN; Meyer B
    Chembiochem; 2012 Mar; 13(4):524-7. PubMed ID: 22266649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4 mimics targeting the HIV entry mechanism and their hybrid molecules with a CXCR4 antagonist.
    Narumi T; Ochiai C; Yoshimura K; Harada S; Tanaka T; Nomura W; Arai H; Ozaki T; Ohashi N; Matsushita S; Tamamura H
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5853-8. PubMed ID: 20728351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the V3 loop involved in HIV binding to CD4?
    Dettin M; Ferranti P; Scarinci C; Picariello G; Di Bello C
    Biochemistry; 2003 Aug; 42(30):9007-12. PubMed ID: 12885233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope.
    Darbha R; Phogat S; Labrijn AF; Shu Y; Gu Y; Andrykovitch M; Zhang MY; Pantophlet R; Martin L; Vita C; Burton DR; Dimitrov DS; Ji X
    Biochemistry; 2004 Feb; 43(6):1410-7. PubMed ID: 14769016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecular CD4 mimics as HIV entry inhibitors.
    Narumi T; Arai H; Yoshimura K; Harada S; Nomura W; Matsushita S; Tamamura H
    Bioorg Med Chem; 2011 Nov; 19(22):6735-42. PubMed ID: 22014753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atomic insight into the CD4 binding-induced conformational changes in HIV-1 gp120.
    Hsu ST; Bonvin AM
    Proteins; 2004 May; 55(3):582-93. PubMed ID: 15103622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection and characterization of an HIV-1 gp120-binding affibody ligand.
    Wikman M; Rowcliffe E; Friedman M; Henning P; Lindholm L; Olofsson S; Ståhl S
    Biotechnol Appl Biochem; 2006 Sep; 45(Pt 2):93-105. PubMed ID: 16712522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computation-guided backbone grafting of a discontinuous motif onto a protein scaffold.
    Azoitei ML; Correia BE; Ban YE; Carrico C; Kalyuzhniy O; Chen L; Schroeter A; Huang PS; McLellan JS; Kwong PD; Baker D; Strong RK; Schief WR
    Science; 2011 Oct; 334(6054):373-6. PubMed ID: 22021856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains.
    Wang JH; Yan YW; Garrett TP; Liu JH; Rodgers DW; Garlick RL; Tarr GE; Husain Y; Reinherz EL; Harrison SC
    Nature; 1990 Nov; 348(6300):411-8. PubMed ID: 1701030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of alpha-helical peptides and mimetics.
    Garner J; Harding MM
    Org Biomol Chem; 2007 Nov; 5(22):3577-85. PubMed ID: 17971985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role of Arg59 in the high-affinity gp120-binding region of CD4 for human immunodeficiency virus type 1 infection.
    Fontenot D; Jones JK; Hossain MM; Nehete PN; Vela EM; Dwyer VA; Jagannadha Sastry K
    Virology; 2007 Jun; 363(1):69-78. PubMed ID: 17320923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. And the best picture is--the HIV gp120 envelope, please!
    Berger EA
    Nat Struct Biol; 1998 Aug; 5(8):671-4. PubMed ID: 9699624
    [No Abstract]   [Full Text] [Related]  

  • 17. Enzymatic labeling of biologically active envelope glycoprotein gp120 of HIV-1.
    Berkower I; Murphy D
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1055-65. PubMed ID: 8466484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4 mimics as HIV entry inhibitors: lead optimization studies of the aromatic substituents.
    Narumi T; Arai H; Yoshimura K; Harada S; Hirota Y; Ohashi N; Hashimoto C; Nomura W; Matsushita S; Tamamura H
    Bioorg Med Chem; 2013 May; 21(9):2518-26. PubMed ID: 23535561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Click chemistry on azidoproline: high-affinity dual antagonist for HIV-1 envelope glycoprotein gp120.
    Gopi HN; Tirupula KC; Baxter S; Ajith S; Chaiken IM
    ChemMedChem; 2006 Jan; 1(1):54-7. PubMed ID: 16892335
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthetic bivalent CD4-mimetic miniproteins show enhanced anti-HIV activity over the monovalent miniprotein.
    Li H; Song H; Heredia A; Le N; Redfield R; Lewis GK; Wang LX
    Bioconjug Chem; 2004; 15(4):783-9. PubMed ID: 15264865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.